The Potential Protective Effects of Taurine on Coronary Heart Disease

Overview

Journal Atherosclerosis

Publisher Elsevier

Specialty Cardiology & Vascular Diseases

Date 2009 Jul 14

PMID 19592001

Citations 76

Authors

Oktawia P Wojcik

Karen L Koenig

Anne Zeleniuch-Jacquotte

Max Costa

Yu Chen

Affiliations

Soon will be listed here.

Abstract

In humans, taurine (2-aminoethanesulfonic acid) is mainly obtained from diet. Despite the fact that the health effects of taurine are largely unknown, taurine has become a popular supplement and ingredient in energy drinks in recent years. Evidence from mechanistic and animal studies has shown that the main biological actions of taurine include its ability to conjugate bile acids, regulate blood pressure (BP), and act as a potent antioxidant and anti-inflammatory agent. These actions suggest that high levels of taurine may be protective against coronary heart disease (CHD). However, data from epidemiologic and intervention studies in humans are limited. We review what is known about taurine's metabolism, its transportation in the body, its food sources, and evidence of its effect on cardiovascular health from in vitro, animal, and epidemiologic studies. We also discuss shortcomings of the human studies that need to be addressed in the future. The identification of taurine as a preventive factor for CHD may be of great public health importance.

Citing Articles

Fluoride impairs vascular smooth muscle A7R5 cell lines via disrupting amino acids metabolism.

Li Y, Yang R, Li X, Liu W, Zhao Y, Zu M J Transl Med. 2024; 22(1):528.

PMID: 38824544 PMC: 11143695. DOI: 10.1186/s12967-024-05350-0.

Metabolomic Biomarkers of Dietary Approaches to Stop Hypertension (DASH) Dietary Patterns in Pregnant Women.

Chen L, Dai J, Yu G, Pang W, Rahman M, Liu X Nutrients. 2024; 16(4).

PMID: 38398816 PMC: 10892314. DOI: 10.3390/nu16040492.

Functional Role of Taurine in Aging and Cardiovascular Health: An Updated Overview.

Santulli G, Kansakar U, Varzideh F, Mone P, Jankauskas S, Lombardi A Nutrients. 2023; 15(19).

PMID: 37836520 PMC: 10574552. DOI: 10.3390/nu15194236.

Oligosaccharides and diet-related dilated cardiomyopathy in beagles.

Bokshowan E, Olver T, Costa M, Weber L Front Vet Sci. 2023; 10:1183301.

PMID: 37565080 PMC: 10411538. DOI: 10.3389/fvets.2023.1183301.

Transcriptomics reveals key genes responsible for functional diversity in muscles of native black Kadaknath and broiler chicken.

Arora R, Sharma R, Ahlawat S, Chhabra P, Kumar A, Kaur M 3 Biotech. 2023; 13(7):253.

PMID: 37396468 PMC: 10310660. DOI: 10.1007/s13205-023-03682-0.

References

Birdsall T . Therapeutic applications of taurine. Altern Med Rev. 1998; 3(2):128-36. View

Kohashi N, Okabayashi T, Hama J, Katori R . Decreased urinary taurine in essential hypertension. Prog Clin Biol Res. 1983; 125:73-87. View

Yamori Y, Liu L, Ikeda K, Miura A, Mizushima S, Miki T . Distribution of twenty-four hour urinary taurine excretion and association with ischemic heart disease mortality in 24 populations of 16 countries: results from the WHO-CARDIAC study. Hypertens Res. 2001; 24(4):453-7. DOI: 10.1291/hypres.24.453. View

Casey R, Gang C, Joyce M, Bouchier-Hayes D . Taurine attenuates acute hyperglycaemia-induced endothelial cell apoptosis, leucocyte-endothelial cell interactions and cardiac dysfunction. J Vasc Res. 2006; 44(1):31-9. DOI: 10.1159/000097893. View

Fujita T, Ando K, Noda H, Ito Y, Sato Y . Effects of increased adrenomedullary activity and taurine in young patients with borderline hypertension. Circulation. 1987; 75(3):525-32. DOI: 10.1161/01.cir.75.3.525. View

Marcinkiewicz J, Grabowska A, Bereta J, Bryniarski K, Nowak B . Taurine chloramine down-regulates the generation of murine neutrophil inflammatory mediators. Immunopharmacology. 1998; 40(1):27-38. DOI: 10.1016/s0162-3109(98)00023-x. View

Nara Y, Yamori Y, Lovenberg W . Effect of dietary taurine on blood pressure in spontaneously hypertensive rats. Biochem Pharmacol. 1978; 27(23):2689-92. DOI: 10.1016/0006-2952(78)90043-6. View

Militante J, Lombardini J . Treatment of hypertension with oral taurine: experimental and clinical studies. Amino Acids. 2002; 23(4):381-93. DOI: 10.1007/s00726-002-0212-0. View

Sethupathy S, Elanchezhiyan C, Vasudevan K, Rajagopal G . Antiatherogenic effect of taurine in high fat diet fed rats. Indian J Exp Biol. 2003; 40(10):1169-72. View

10.

Huxtable R . Physiological actions of taurine. Physiol Rev. 1992; 72(1):101-63. DOI: 10.1152/physrev.1992.72.1.101. View

11.

Park E, QUINN M, Wright C, Schuller-Levis G . Taurine chloramine inhibits the synthesis of nitric oxide and the release of tumor necrosis factor in activated RAW 264.7 cells. J Leukoc Biol. 1993; 54(2):119-24. DOI: 10.1002/jlb.54.2.119. View

12.

Lourenco R, Camilo M . Taurine: a conditionally essential amino acid in humans? An overview in health and disease. Nutr Hosp. 2003; 17(6):262-70. View

13.

Sole M, Jeejeebhoy K . Conditioned nutritional requirements and the pathogenesis and treatment of myocardial failure. Curr Opin Clin Nutr Metab Care. 2000; 3(6):417-24. DOI: 10.1097/00075197-200011000-00001. View

14.

Chen W, Matuda K, Nishimura N, Yokogoshi H . The effect of taurine on cholesterol degradation in mice fed a high-cholesterol diet. Life Sci. 2004; 74(15):1889-98. DOI: 10.1016/j.lfs.2003.08.041. View

15.

Yamori Y, Murakami S, Ikeda K, Nara Y . Fish and lifestyle-related disease prevention: experimental and epidemiological evidence for anti-atherogenic potential of taurine. Clin Exp Pharmacol Physiol. 2005; 31 Suppl 2:S20-3. DOI: 10.1111/j.1440-1681.2004.04122.x. View

16.

Yamori Y, Liu L, Mizushima S, Ikeda K, Nara Y . Male cardiovascular mortality and dietary markers in 25 population samples of 16 countries. J Hypertens. 2006; 24(8):1499-505. DOI: 10.1097/01.hjh.0000239284.12691.2e. View

17.

Hayes K, Sturman J . Taurine in metabolism. Annu Rev Nutr. 1981; 1:401-25. DOI: 10.1146/annurev.nu.01.070181.002153. View

18.

Schaffer S, Lombardini J, Azuma J . Interaction between the actions of taurine and angiotensin II. Amino Acids. 2000; 18(4):305-18. DOI: 10.1007/pl00010320. View

19.

Zhang M, Bi L, Fang J, Su X, Da G, Kuwamori T . Beneficial effects of taurine on serum lipids in overweight or obese non-diabetic subjects. Amino Acids. 2004; 26(3):267-71. DOI: 10.1007/s00726-003-0059-z. View

20.

Fujita T, Sato Y . Hypotensive effect of taurine. Possible involvement of the sympathetic nervous system and endogenous opiates. J Clin Invest. 1988; 82(3):993-7. PMC: 303613. DOI: 10.1172/JCI113709. View